SnagRx review
Four billing cycles are published on each molecule, and the gap between the shortest and the longest is only thirty dollars a month.
The verdict
SnagRx publishes compounded semaglutide at $99, $89, $79 and $69 a month across one, three, six and twelve-month cycles. Tirzepatide runs $149, $139, $129 and $119. Every rung holds at every dose.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 sellers by price
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- From
- From $99/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- All 50 states claimed, except Louisiana; Nebraska limited
SnagRx sells both molecules by injection. There is no oral line. The whole ladder is published on the product page rather than revealed at checkout.
Who writes the prescription, and what do they see?
A prescription is required before dispensing. The pages describe the plans rather than the clinician. Nothing states who writes it, or what the intake covers.
A prescription is required before anything ships. The pricing page is the strong part of this seller: four terms, two molecules, and a stated flat rate at every dose on all eight combinations.
What happens when the dose goes up?
Every rung is stated to hold at every dose, on both molecules. That covers all eight price-and-term combinations, so escalating through the first four months changes nothing about the bill.
What the price includes
The one-month rate is $99 and $149, and those are the figures to budget from. Committing a full year takes $30 off each, reaching $69 and $119. That is a thinner reward for a year than most sellers offer, so the flexible rung costs little to keep. Six months at the one-month rate is $594 and $894.
What it claims, and what it cites
Both lines are compounded rather than manufactured. A pharmacy prepares them to order, and the FDA does not review a compounded preparation before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: The whole ladder is published, not revealed at checkout
- Strength: Flat at every dose on all eight combinations
- Strength: Staying flexible costs only $30 a month
- Limitation: A year of commitment buys very little
- Limitation: Struck-through anchors nobody is charged
- Limitation: No refund terms published
- Limitation: No pharmacy named and no state list recorded
What the evidence says about this kind of treatment
The assessment above is about SnagRx. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A buyer who wants to stay month to month without paying much for it.
- Wrong for
- A buyer hunting the steepest annual discount.
The evidence behind what SnagRx prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How SnagRx compares
| Seller | Who it suits | Go |
|---|---|---|
 Science & Co | Patients who clarify the clinician, pharmacy and full plan terms before enrolling | See Science & Co → |
 Lean Meds | Readers willing to clarify the prescription and renewal details | See Lean Meds → |
| EverSlim | A reader who wants one monthly charge covering the medication, the visit and the postage, without a prepay term attached to reach the rate. | See EverSlim → |
More GLP-1 sellers by price reviews: PeterMDRxSpan MDSesame CareShedRxSkinnyRxSprout Health
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- What does a month cost without committing?
- $99 for compounded semaglutide and $149 for tirzepatide, and both hold at every dose.
- Is the annual plan worth it?
- It saves $30 a month on either molecule. That is a smaller gap than most sellers offer for a year, so the flexibility is cheap to keep.
- What are the struck-through figures?
- $299 and $399 appear crossed out on the homepage. Nothing indicates either is a rate anyone is charged.
- Is SnagRx expensive compared with other GLP-1 sellers by price?
- SnagRx publishes a starting figure of $99/mo. Across the 402 GLP-1 sellers by price we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts SnagRx below the median, toward the cheaper end. The other 178 GLP-1 sellers by price we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.